Dr. Peter Gottlieb, MD
Claim this profileUniversity of Colorado School of Medicine: Barbara Davis Center for Diabetes
Studies Diabetes Mellitus
Studies Type 1 Diabetes
4 reported clinical trials
4 drugs studied
Area of expertise
1Diabetes Mellitus
ZnT8 positive
GAD-65 positive
Insulin positive
2Type 1 Diabetes
ZnT8 positive
GAD-65 positive
Insulin positive
Affiliated Hospitals
Clinical Trials Peter Gottlieb, MD is currently running
MAS-1 Adjuvanted Immunotherapy
for Type 1 Diabetes
This trial tests a new vaccine mixed with a booster substance to help patients with type 1 diabetes. The goal is to retrain their immune system to stop attacking insulin-producing cells, potentially improving their condition.
Recruiting1 award Phase 19 criteria
Rituximab + Abatacept
for Type 1 Diabetes
This trial is testing whether a combination of two drugs, rituximab-pvvr followed by abatacept, can better preserve insulin production in people newly diagnosed with Type 1 Diabetes compared to rituximab-pvvr alone. Rituximab-pvvr works by reducing harmful immune cells, while abatacept helps calm the immune system. The goal is to see if this combination can improve insulin production and overall diabetes management.
Recruiting0 awards Phase 220 criteria
More about Peter Gottlieb, MD
Clinical Trial Related4 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Peter Gottlieb, MD has experience with
- MAS-1 Adjuvanted Insulin B-chain
- Siplizumab
- Abatacept
- Rituximab
Breakdown of trials Peter Gottlieb, MD has run
Diabetes Mellitus
Type 1 Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Peter Gottlieb, MD specialize in?
Peter Gottlieb, MD focuses on Diabetes Mellitus and Type 1 Diabetes. In particular, much of their work with Diabetes Mellitus has involved ZnT8 positive patients, or patients who are GAD-65 positive.
Is Peter Gottlieb, MD currently recruiting for clinical trials?
Yes, Peter Gottlieb, MD is currently recruiting for 2 clinical trials in Aurora Colorado. If you're interested in participating, you should apply.
Are there any treatments that Peter Gottlieb, MD has studied deeply?
Yes, Peter Gottlieb, MD has studied treatments such as MAS-1 adjuvanted Insulin B-chain, Siplizumab, Abatacept.
What is the best way to schedule an appointment with Peter Gottlieb, MD?
Apply for one of the trials that Peter Gottlieb, MD is conducting.
What is the office address of Peter Gottlieb, MD?
The office of Peter Gottlieb, MD is located at: University of Colorado School of Medicine: Barbara Davis Center for Diabetes, Aurora, Colorado 80045 United States. This is the address for their practice at the University of Colorado School of Medicine: Barbara Davis Center for Diabetes.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.